# Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)

> **NCT01463696** · PHASE1 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 48 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** MK-8242

## Key facts

- **NCT ID:** NCT01463696
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12-21
- **Primary completion:** 2014-09-15
- **Final completion:** 2015-10-15
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01463696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01463696, "Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01463696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*